ENTITY
Novo Nordisk

Novo Nordisk (NOVOB DC)

75
Analysis
Health Care • Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
bearish•MSCI World Index
•20 Mar 2020 04:41

Dollar Surge Further Aggravates Equity Markets

Support levels have meant little more than talking points as indexes are slicing through them like butter. The truth remains that no one knows how...

Logo
594 Views
Share
bullish•MSCI World Index
•11 Dec 2019 07:37

Global Equities Headed Up and to the Right: Technology, Health Care Leading

Our weight of the evidence approach leads us to believe the market remains in the early stages of a broad-based advance, meaning a buy-the-dip...

Logo
556 Views
Share
•01 Nov 2019 20:34

Developed Markets Strategy: Stick with Japan

Despite EAFE’s YTD outperformance relative to EM, EAFE and EM returns have generally been equal since August, shown by the stalemate in the EAFE...

Logo
654 Views
Share
bullish•MSCI World Index
•09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
483 Views
Share
•28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
773 Views
Share
x